NCT05634577 2025-06-19
A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
M.D. Anderson Cancer Center
Phase 2 Terminated
Clinical Trials
4 trialsNCT00094497 2016-09-21
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Collaborative Group for Adrenocortical Carcinoma Treatment
Phase 3 Completed
NCT02057237 2015-12-17
A Safety and Feasibility Study of Mitotane in Prostate Cancer
University Health Network, Toronto
Phase 1 Completed
NCT00778817 2014-04-29
IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Terminated